Koss-Olinger Consulting’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-8,762
Closed -$209K – 273
2025
Q4
$209K Sell
8,762
-5,747
-40% -$143K 0.02% 260
2025
Q3
$415K Hold
14,509
– – 0.03% 228
2025
Q2
$415K Sell
14,509
-491
-3% -$13.2K 0.03% 229
2025
Q1
$374K Hold
15,000
– – 0.03% 234
2024
Q4
$340K Hold
15,000
– – 0.03% 152
2024
Q3
$320K Hold
15,000
– – 0.03% 218
2024
Q2
$286K Buy
+15,000
New +$306K 0.03% 220
2024
Q1
– Sell
-25,955
Closed -$541K – 134
2023
Q4
$541K Sell
25,955
-51,131
-66% -$982K 0.05% 142
2023
Q3
$1.66M Sell
77,086
-19,220
-20% -$467K 0.24% 53
2023
Q2
$2.31M Buy
96,306
+2,219
+2% +$50.9K 0.27% 39
2023
Q1
$2M Buy
94,087
+1,217
+1% +$23.3K 0.25% 41
2022
Q4
$1.52M Buy
92,870
+67,170
+261% +$996K 0.22% 50
2022
Q3
$361K Buy
+25,700
New +$486K 0.06% 124
2021
Q4
– Sell
-7,330
Closed -$256K – 235
2021
Q3
$256K Buy
+7,330
New +$286K 0.04% 190

Other funds holding FMS

Koss-Olinger Consulting's FMS Position: Q1 2026 in Review

Koss-Olinger Consulting sold out of Fresenius Medical Care (FMS) in Q1 2026, closing a stake of 8,762 shares — an estimated $209K sold.

Koss-Olinger Consulting first reported a position in FMS in Q3 2021 and held it in 14 quarters. The position peaked at $2.31M in Q2 2023. 220 funds tracked by Wall St. Rank hold FMS as of Q1 2026.

  • Koss-Olinger Consulting reported no remaining Fresenius Medical Care position as of Q1 2026 after selling out during the quarter.
  • Koss-Olinger Consulting sold 8,762 Fresenius Medical Care shares in Q1 2026, an estimated $209K.
  • Koss-Olinger Consulting first reported a position in Fresenius Medical Care in Q3 2021 and held it in 14 quarters.
  • Koss-Olinger Consulting's Fresenius Medical Care position peaked at $2.31M in Q2 2023.
  • 220 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.

Based on Koss-Olinger Consulting's 13F filing for Q1 2026, filed 7 May 2026.